Share of InflaRx are up 97c, or 47%, to $3.02 in afternoon trading.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on IFRX:
- InflaRx (NASDAQ:IFRX) Stock Spikes: Is There Further Upside?
- InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
- InflaRx announces Gohibic receives FDA Emergency Use Authorization
- InflaRx reports FY22 EPS (EUR0.67) vs EUR 1.10 last year
- InflaRx Reports Full Year 2022 Financial and Operating Results